Sponsored Links

Adalimumab Levels Detected In Cord Blood And Infants Exposed In Utero PDF Print E-mail
Medical News - Crohn's
Adalimumab (ADA), a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers at the University of California San Francisco have found...

Read more: Crohn's / IBD News From Medical News Today